These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 10028046

  • 1. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
    Murray M.
    Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K, Dressman JB.
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [Abstract] [Full Text] [Related]

  • 3. Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants.
    Bachmann KA, Lewis JD.
    Ann Pharmacother; 2005 Jun; 39(6):1064-72. PubMed ID: 15886285
    [Abstract] [Full Text] [Related]

  • 4. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M, Petrovic N.
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [Abstract] [Full Text] [Related]

  • 5. Inhibition and induction of human cytochrome P450 enzymes: current status.
    Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H.
    Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
    [Abstract] [Full Text] [Related]

  • 6. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T, Price A.
    Am Fam Physician; 2007 Aug 01; 76(3):391-6. PubMed ID: 17708140
    [Abstract] [Full Text] [Related]

  • 7. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A, Komorowski J, Wikberg JE.
    J Chem Inf Model; 2008 Sep 01; 48(9):1840-50. PubMed ID: 18693719
    [Abstract] [Full Text] [Related]

  • 8. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P, Poggesi I.
    Eur J Med Chem; 2006 Jul 01; 41(7):795-808. PubMed ID: 16644065
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF, Liu JP, Chowbay B.
    Drug Metab Rev; 2009 Jul 01; 41(2):89-295. PubMed ID: 19514967
    [Abstract] [Full Text] [Related]

  • 10. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J, Amin Usmani K, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Apr 15; 147(3):319-29. PubMed ID: 15135087
    [Abstract] [Full Text] [Related]

  • 11. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.
    Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM.
    J Pharmacol Exp Ther; 2006 Jan 15; 316(1):336-48. PubMed ID: 16192315
    [Abstract] [Full Text] [Related]

  • 12. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
    Muruganandan S, Sinal CJ.
    Clin Pharmacol Ther; 2008 Jun 15; 83(6):818-28. PubMed ID: 18388875
    [Abstract] [Full Text] [Related]

  • 13. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K, Khattar SK, Saini KS.
    Cancer Lett; 2008 Jan 18; 259(1):1-15. PubMed ID: 18053638
    [Abstract] [Full Text] [Related]

  • 14. Cytochromes P450 and drug discovery.
    Lamb DC, Waterman MR, Kelly SL, Guengerich FP.
    Curr Opin Biotechnol; 2007 Dec 18; 18(6):504-12. PubMed ID: 18006294
    [Abstract] [Full Text] [Related]

  • 15. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ.
    Drug Discov Today; 2006 Jul 18; 11(13-14):601-6. PubMed ID: 16793528
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 and its role in veterinary drug interactions.
    Trepanier LA.
    Vet Clin North Am Small Anim Pract; 2006 Sep 18; 36(5):975-85, v. PubMed ID: 16984823
    [Abstract] [Full Text] [Related]

  • 17. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW, Frishman WH, Aronow WS.
    Am J Ther; 2009 Sep 18; 16(2):155-63. PubMed ID: 19114873
    [Abstract] [Full Text] [Related]

  • 18. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
    Usmani KA, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Dec 07; 150(3):221-32. PubMed ID: 15560889
    [Abstract] [Full Text] [Related]

  • 19. Classification of cytochrome P450 inhibitors with respect to binding free energy and pIC50 using common molecular descriptors.
    Dagliyan O, Kavakli IH, Turkay M.
    J Chem Inf Model; 2009 Oct 07; 49(10):2403-11. PubMed ID: 19777996
    [Abstract] [Full Text] [Related]

  • 20. CYP enzymes and adverse drug reactions.
    Wynn RL, Meiller TF.
    Gen Dent; 1998 Oct 07; 46(5):436-8. PubMed ID: 10202487
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.